The Utility of Osteopathic Manipulative Medicine in Weaning Patients from the Ventilator Pilot Trial
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The objectives of this research are to determine the treatment effect size of OMM to wean patients off of the ventilator, determine the number of patients needed for a larger study (power), determine the willingness of patients/POAs to be recruited, identify the correct dosing of OMM and whether there are concerns for the safety of treatment, and determine whether the hypothesis is feasible for a larger study. The primary outcome measure is the duration of time until a subject is weaned off of mechanical ventilation using Osteopathic Manipulative Medicine (OMM). The secondary outcome measures (see the next section for further explanation) are to determine if OMM affects changes in morbidity and mortality, such as VBG/ABG, NIF, RSBI, P 0.1, FiO2, PEEP, mental status, hemodynamic stability (blood pressure), spontaneous TV, reintubation after extubation, and death.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2025
CompletedStudy Start
First participant enrolled
March 17, 2025
CompletedFirst Posted
Study publicly available on registry
March 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2025
CompletedMarch 24, 2025
March 1, 2025
3 months
March 12, 2025
March 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Time on ventilator
Number of days that the patient is on the ventilator after inclusion in the study
90 days
Secondary Outcomes (11)
Ventilator associated measurement
90 days
Ventilator associated measurement
90 days
Ventilator associated measurement
90 days
Ventilator associated measurement
90 days
Ventilator associated measurement
90 days
- +6 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONSubjects in these arms only receive conventional care
Osteopathic Manipulative Treatment
EXPERIMENTALThe standard OMM treatment arm includes a 10-minute treatment time for 5 body regions with up to 3 providers working on the patient simultaneously. The OMM attending physician will be physically present and supervising the treatment, and may be participating in the treatment. The 5 body regions include Head, Neck, Thoracic, Ribs, and Abdominal/Diaphragm. The standard technique for the OMM arm includes OA decompression, screening and treating any cervical dysfunction, thoracic inlet myofascial release, rib raising, thoracic paraspinal inhibition, and abdominal diaphragm myofascial release. There is an opportunity for an additional 5 minutes of treatment time and additional regions if the lead physician determines it is appropriate based on clinical judgment. The additional 4 regions include Upper Extremity, Lower Extremity, Lumbar, Pelvis, and Sacrum.
Interventions
Eligibility Criteria
You may qualify if:
- Acute respiratory failure (hypoxic, hypercapnic, or neuromuscular)
- Not making satisfactory progress with weaning after being on the ventilator for more than 48 hours
- Clinical stability for pressure support trial with ventilator to monitor ventilation progression
- Pulmonology must be following the patient for standardized ventilator management approach and interventions as needed
- Medical power of attorney (POA) or legally authorized representative (LAR) who is able to consent subject for trial enrollment and treatment
- Patients who were not referred to the OMM service
You may not qualify if:
- Age less than 18 years old or more than 85 years old
- BMI\>60
- Moderate/severe neurological disease with expectation of non-progression off the ventilator or poor quality of life predicted (including end-stage dementia with the expectation of non-progression off ventilator, multiple sclerosis, ALS, anoxic brain injury, etc)
- Status epilepticus or EEG result pending
- Post-arrest hypothermia protocol
- Acute stroke
- Acute rib fractures preventing the implementation of the treatment protocol
- Acute spinal injury preventing the implementation of the treatment protocol
- Recent head injury requiring close clinical monitoring
- Ejection Fraction less than 15%
- Pleural effusion requiring procedural intervention or inhibiting ventilator progress
- Pericardial effusion or tamponade requiring procedural intervention or inhibiting ventilator progress
- ACLS/cardiac arrest within the past 72 hours
- Confirmed opioid overdose with positive urine drug screen and response to naloxone
- Patients who were referred to the OMM service
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Amber Hood, DFS
OSU CHS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
March 12, 2025
First Posted
March 24, 2025
Study Start
March 17, 2025
Primary Completion
June 8, 2025
Study Completion
June 8, 2025
Last Updated
March 24, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share